Renata Pharma

Renata Pharma

Representational image. Photo: Collected

Renata delivers 25% profit growth in Jul-Dec

Exports in Q2 fell 23% as orders deferred after inventory damaged in Dhaka airport fire

Renata expands global footprint with Turkey regulatory approval

Renata expands global footprint with Turkey regulatory approval

Renata launches Fludrocortisone tablets in UK

Renata launches Fludrocortisone tablets in UK

Renata PLC launches Cabergoline in France and Nordic Countries

Renata PLC launches Cabergoline in France and Nordic Countries

Renata’s Mirpur facility earns Bangladesh’s first EU GMP

Renata’s Mirpur facility earns Bangladesh’s first EU GMP

Renata earns EU GMP certification, eyes expansion in global markets

Renata earns EU GMP certification, eyes expansion in global markets

Renata’s manufacturing standards win european recognition

Renata’s manufacturing standards win european recognition

Renata PLC expands global reach with UK launch of Cabergoline

Renata PLC expands global reach with UK launch of Cabergoline

Renata sets preference shares conversion at Tk475 each

Renata sets preference shares conversion at Tk475 each

Renata to issue Tk325cr preference shares

Renata to issue Tk325cr preference shares

Infographic: TBS

Renata's revenue, profit surged by 14%, 55% in FY24

Renata's Cabergoline 0.5mg tablets received approval from the EU Decentralized Procedure (DCP). The medicine is sold in Bangladesh under the name Cabolin. Photo: Collected

Renata can now export drug for Parkinson's disease to Europe

Renata set to pay off short-term loans with bond finance

Renata set to pay off short-term loans with bond finance